NCT00722306View on ClinicalTrials.gov

A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Insomnia
Interventions
DRUG

PD 0200390

Extemporaneous solution of C14 Labelled PD 0200390 60 mg single dose

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00722306 - A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers | Biotech Hunter | Biotech Hunter